1. Home
  2. CVKD vs VEEE Comparison

CVKD vs VEEE Comparison

Compare CVKD & VEEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVKD
  • VEEE
  • Stock Information
  • Founded
  • CVKD 2022
  • VEEE 1994
  • Country
  • CVKD United States
  • VEEE United States
  • Employees
  • CVKD N/A
  • VEEE N/A
  • Industry
  • CVKD Medicinal Chemicals and Botanical Products
  • VEEE Marine Transportation
  • Sector
  • CVKD Health Care
  • VEEE Industrials
  • Exchange
  • CVKD Nasdaq
  • VEEE Nasdaq
  • Market Cap
  • CVKD 8.2M
  • VEEE 5.3M
  • IPO Year
  • CVKD 2023
  • VEEE 2021
  • Fundamental
  • Price
  • CVKD $0.43
  • VEEE $0.50
  • Analyst Decision
  • CVKD Strong Buy
  • VEEE
  • Analyst Count
  • CVKD 2
  • VEEE 0
  • Target Price
  • CVKD $3.50
  • VEEE N/A
  • AVG Volume (30 Days)
  • CVKD 71.0K
  • VEEE 88.1K
  • Earning Date
  • CVKD 08-12-2024
  • VEEE 08-12-2024
  • Dividend Yield
  • CVKD N/A
  • VEEE N/A
  • EPS Growth
  • CVKD N/A
  • VEEE N/A
  • EPS
  • CVKD N/A
  • VEEE N/A
  • Revenue
  • CVKD N/A
  • VEEE $29,922,530.00
  • Revenue This Year
  • CVKD N/A
  • VEEE $76.99
  • Revenue Next Year
  • CVKD N/A
  • VEEE N/A
  • P/E Ratio
  • CVKD N/A
  • VEEE N/A
  • Revenue Growth
  • CVKD N/A
  • VEEE N/A
  • 52 Week Low
  • CVKD $0.36
  • VEEE $0.48
  • 52 Week High
  • CVKD $2.17
  • VEEE $2.33
  • Technical
  • Relative Strength Index (RSI)
  • CVKD 41.09
  • VEEE 39.88
  • Support Level
  • CVKD $0.43
  • VEEE $0.51
  • Resistance Level
  • CVKD $0.49
  • VEEE $0.61
  • Average True Range (ATR)
  • CVKD 0.02
  • VEEE 0.06
  • MACD
  • CVKD -0.00
  • VEEE 0.00
  • Stochastic Oscillator
  • CVKD 6.67
  • VEEE 10.41

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

About VEEE Twin Vee PowerCats Co.

Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power catamaran boats to use for fishing, diving and water skiing and commercial activities including transportation, eco-tours, fishing, and diving expeditions. Its revenue is derived from the sale of boats, motors, and trailers to its independent dealers. It has organized its business into three operating segments: The gas-powered boat segment, which manufactures and distributes gas-powered boats; The electric-powered boat segment, which is developing fully electric boats, through its controlling interest subsidiary, and its franchise segment, which is developing a standard product offering and will be selling franchises across the United States through its wholly-owned subsidiary.

Share on Social Networks: